Kim, Jung Eun

USPTO Trademark & Patent Filings

Kim Jung Eun

Trademark applications and grants for Kim, Jung Eun. Kim, Jung Eun has 2 trademark applications. The latest application filed is for "QOVIT"

Company Profile
    Company Aliases
  • Kim, Jung Eun
  • eun jung kim
  • KIM; Jung Eun - Yongin-si KR
  • KIM; Jung Eun - Daejeon KR
  • KIM; Jung Eun - Incheon KR
  • Kim; Jung Eun - Daejeon KR
  • KIM; Jung-eun - Seongnam-si KR
  • Kim; Jung Eun - San Francisco CA
  • Kim; Jung Eun - Seoul KR
Entity Type INDIVIDUAL
Address E-302, Terrace29 8, Domachi-ro 89beon-gil, Suji-gu Yongin-si, Gyeonggi-do KOREA, REPUBLIC OF 16807

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
SYSTEM FOR EVALUATING SENSITIVITY TO ANTI-CANCER AGENT AND A COMPUTER READABLE MEDIUM STORING PROGRAMS EXECUTING AN EVALUATING METHOD
20220310273 - 17/239118 KU; Bo Sung ;   et al.
2022-09-29
METHOD FOR PREPARING CARBOXYLIC ACID MODIFIED-NITRILE BASED COPOLYMER LATEX
20220306843 - 17/606126 KIM; Jung Eun ;   et al.
2022-09-29
NOVEL LOBARIC ACID DERIVATIVE HAVING PTP-1B INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF
20220281805 - 17/637439 YIM; Joung Han ;   et al.
2022-09-08
Carboxylic Acid Modified-Nitrile Based Copolymer Latex
20220251346 - 17/439979 Kwon; Won Sang ;   et al.
2022-08-11
METHOD AND SYSTEM FOR OPTIMIZING REINFORCEMENT-LEARNING-BASED AUTONOMOUS DRIVING ACCORDING TO USER PREFERENCES
20220229435 - 17/657878 CHOI; Jinyoung ;   et al.
2022-07-21
Systems, methods, and apparatuses for resuming dialog sessions via automated assistant
11,264,033 - 16/359,179 Aggarwal , et al. March 1, 2
2022-03-01
Systems, methods, and apparatuses for resuming dialog sessions via automated assistant
11,232,795 - 16/359,179 Aggarwal , et al. January 25, 2
2022-01-25
RNA guided endonuclease targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same
11,202,839 - 15/807,844 Kim , et al. December 21, 2
2021-12-21
Talen targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same
11,197,935 - 15/807,850 Kim , et al. December 14, 2
2021-12-14
Endonuclease targeting blood coagulation factor VIII gene and composition for treating hemophilia comprising same
11,185,596 - 15/541,784 Kim , et al. November 30, 2
2021-11-30
Patent Grants & Applications
Trademark Applications
Mark Image

Registration | Serial
Trademark
Application Date
 QOVIT
"QOVIT"
88720807
QOVIT
2019-12-10
 POSSI.ATTI
"POSSI.ATTI"
3175546 78686626
POSSI.ATTI
2005-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed